PN
The Pennant Group, Inc.
PNTG · NASDAQ
$42.48 +6.04% (+$2.42)
1M +2.02%
Market Cap $1.39B
P/E Ratio 43.00x
Div. Yield -
ROE 9.51%
Bulios Fair Price
$24.06
43.4% downside
Current Price
$42.48
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PNTG is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
22 /100
Expensive EV/EBITDA 28.61x
P/S 1.26x
P/B 3.87x
Growth
100 /100
Growing Rev. growth 26.05%
Book val. growth 40.08%
EPS growth 56.30%
Profitability
22 /100
Weak Net margin 2.93%
Op. margin 5.77%
FCF margin 2.36%
Quality
41 /100
Average ROE 9.51%
ROA 3.12%
Asset turnover 1.06x
Debt
39 /100
Moderate Current ratio 1.20x
Int. coverage 12.12x
Net debt/EBITDA 7.33x
Stability
70 /100
Stable Rev. volatility 10.64%
EPS volatility 40.86%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PNTG
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Brent J. Guerisoli
Employees
9,700
Headquarters
Eagle
Upcoming events
04 NOV
Earnings
Upcoming earnings report